~ Dec 07 Hidden Dangers Of Acetaminophen - References


1. Eriksson LS, Broome U, Kalin M, Lindholm M. Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med. 1992 May;231(5):567-70.

2. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):398-405.

3. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17;137(12):947-54.

4. Lee WM. Acetaminophen and the US Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004 Jul;40(1):6-9.

5. Available at: http://www.emedicine.com/ped/topic7.htm. Accessed September 20, 2007.

6. Acetaminophen Alert. Consumer Reports. May, 2006:44.

7. MacDonald TM. Acetaminophen: risk-management urgently required. Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):406-9.

8. Larson AM, Polson JS, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364-72.

9. Osborne ZP, Bryant SM. Patients discharged with a prescription for acetaminophen-containing narcotic analgesics do not receive appropriate written instructions. Am J Emerg Med. 2003 Jan;21(1):48-50.

10. Gyamlani GG, Parikh CR. Acetaminophen toxicity: suicidal vs. accidental. Crit Care. 2002 Apr;6(2):155-9.

11. Tylenol® Extra Strength Acetaminophen. Warnings on package. McNeil Consumer Healthcare, 2006.

12. Moling O, Cairon E, Rimenti G, et al. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther. 2006 May;28(5):755-60.

13. Lane JE, Belson MG, Brown DK, Scheetz A. Chronic acetaminophen toxicity: a case report and review of the literature. J Emerg Med. 2002 Oct;23(3):253-6.

14. Roberge R. Chronic acetaminophen toxicity. J Emerg Med. 2003 Nov;25(4):474.

15. Kadas I, Konczol F, Illes T. Fatal acute liver damage caused by a therapeutic dose of paracetamol. Orv Hetil. 1998 Jan 25;139(4):189-91.

16. Muniz AE, Rose SR, Liner SR, Foster RL. Unsuspected acetaminophen toxicity in a 58-day-old infant. Pediatr Emerg Care. 2004 Dec;20(12):824-8.

17. Shahroor S, Shvil Y, Ohali M, Granot E. Acetaminophen toxicity in children as a "therapeutic misadventure". Harefuah. 2000 Apr 16;138(8):654-7, 710.

18. Available at: http://www.fda.gov/bbs/topics/NEWS/2004/NEW01008.html. Accessed September 20, 2007.

19. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006 Jul 5;296(1):87-93.

20. Ahmad SR. Safety of recommended doses of paracetamol. Lancet. 2007 Feb 10;369(9560):462-3.

21. Smith SW. Sidelining safety—the FDA's inadequate response to the IOM. N Engl J Med. 2007 Sep 6;357(10):960-3.

22. Center for Drug Evaluation and Research. Guidance For Industry: Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Product. US Food and Drug Administration, June 2006.

23. Price VF, Miller MG, Jollow DJ. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol. 1987 Feb 15;36(4):427-33.

24. Tokatli A, Kalkanoglu-Sivri HS, Yuce A, Coskun T. Acetaminophen-induced hepatotoxicity in a glutathione synthetase-deficient patient. Turk J Pediatr. 2007 Jan;49(1):75-6.

25. The dangers of acetaminophen. Harvard Health Letter. July, 2001:6.

26. Davern TJ. Acetaminophen hepatotoxicity. Hepatology. 2004 Oct;40(4):1021-2.

27. Murphy CA, Dargie HJ. Drug-induced cardiovascular disorders. Drug Saf. 2007;30(9):783-804.

28. Sopena F, Lanas A. How to advise aspirin use in patients who need NSAIDs. Curr Pharm Des. 2007;13(22):2248-60.

29. Available at: www.lef.org/protocols/appendix/otc_toxicity_01.htm. Accessed September 10, 2007.

30. Chen TS, Richie JP Jr, Lang CA. Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos. 1990 Nov-Dec;18(6):882-7.

31. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007 Aug;7(4):355-9.

32. Hill AS, Rogers QR, O'Neill SL, Christopher MM. Effects of dietary antioxidant supplementation before and after oral acetaminophen challenge in cats. Am J Vet Res. 2005 Feb;66(2):196-204.

33. Faintuch J, Aguilar PB, Nadalin W. Relevance of N-acetylcysteine in clinical practice: Fact, myth or consequence? Nutrition. 1999 Feb;15(2):177–9.

34. Lieber CS. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol. 2002 Jul;27(3):173-7. Review.

35. Tseng YM, Lin SK, Hsiao JK, et al. Whey protein concentrate promotes the production of glutathione (GSH) by GSH reductase in the PC12 cell line after acute ethanol exposure. Food Chem Toxicol. 2006 Apr;44(4):574-8.

36. Marshall K. Therapeutic applications of whey protein. Altern Med Rev. 2004 Jun;9(2):136-56

37. Lands LC, Grey VL, Smountas AA. Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol. 1999 Oct;87(4):1381-5.

38. Muriel P, Garciapiña T, Perez-Alvarez V, Mourelle M. Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol. 1992 Dec;12(6):439-42.

39. Basaga H, Poli G, Tekkaya C, Avas I. Free radical scavenging and antioxidative properties of ‘silibin' complexes on microsomal lipid peroxidation. Cell Biochem Funct. 1997 Mar;15(1):27–33.

40. Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev. 2004 Oct;36(3-4):511-29. Review.

41. Anand BS, Romero JJ, Sanduja SK, Lichtenberger LM. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol. 1999 Jul;94(7):1818-22.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.